伴纤维蛋白原异常的IgA-λ型多发性骨髓瘤1例并文献复习
IgA-λ Multiple Myeloma with Abnormal Fibrigon: A Case Report and Literature Review
摘要: 多发性骨髓瘤是浆细胞恶性克隆性疾病,临床表现多样,少数患者存在出血倾向,以鼻出血和牙龈出血多见,本例患者为中老年女性,首发鼻出血及皮肤出血,测纤维蛋白原明显减低,骨穿见成熟红细胞呈明显缗钱状排列,原幼浆细胞占ANC 54.5%,免疫球蛋白(血):IgA 87.70 g/L,λ轻链23.70 g/L。诊断:多发性骨髓瘤(IgA-λ型)。
Abstract: Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells with various clinical manifestations. A few patients have bleeding tendency, especially nosebleeds and gingival bleeding. This patient is a middle-aged and old woman, with epistaxis and skin bleeding as the first manifestations. The fibrinogen is obviously reduced, and the mature red blood cells are obviously arranged in a money-like way after bone penetration. The protoplasmic cells account for 54.5% of ANC, and immunoglobulin (blood): IgA 87.70 g/L, λ 23.70 g/L. Diagnosis: Multiple myeloma (IgA-λ type).
文章引用:李金玉, 杜娟, 孙玉娇, 颜学申, 李广伦, 牛文验, 崔中光. 伴纤维蛋白原异常的IgA-λ型多发性骨髓瘤1例并文献复习[J]. 临床医学进展, 2021, 11(7): 3113-3116. https://doi.org/10.12677/ACM.2021.117451

参考文献

[1] Rajkumar, S.V., Dimopoulos, M.A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.V., et al. (2014) International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma. Lancet Oncology, 15, e538-e548. [Google Scholar] [CrossRef
[2] Kotlín, R., Sobotková, A., Riedel, T., et al. (2008) Acquired Dysfibrinogenemia Secondary to Multiple Myeloma. Acta Haematologica, 120, 75-81. [Google Scholar] [CrossRef] [PubMed]
[3] Mosesson, M.W. (2010) Fibrinogen and Fibrin Structure and Functions. Journal of Thrombosis & Haemostasis, 3, 1894-1904. [Google Scholar] [CrossRef] [PubMed]
[4] Casini, A., Neerman-Arbez, M., Ariëns, R.A., et al. (2015) Dysfibrinogenemia: From Molecular Anomalies to Clinical Manifestations and Management. Journal of Thrombosis and Haemostasis, 13, 909-919. [Google Scholar] [CrossRef] [PubMed]
[5] Regañón, E., Vila, V., Aznar, J., Garrido, G., Estellés, A. and Berenguer, J. (1987) Study of the Formation of Fibrin Clot in Cirrhotic Patients: An Approach to Study of Acquired Dysfibrinogenemia. Thrombosis Research, 46, 705-714. [Google Scholar] [CrossRef] [PubMed]
[6] Moerloose, P.D., Casini, A. and Neerman-Arbez, M. (2013) Congenital Fibrinogen Disorders: An Update. Seminars in Thrombosis and Hemostasis, 39, 585-595. [Google Scholar] [CrossRef] [PubMed]
[7] Arai, S., Kamijo, T., Takezawa, Y., Sugano, M., Nakazawa, H., Yanagisawa, R., Uehara, T., Honda, T. and Okumura, N. (2020) Acquired Dysfibrinogenemia: Monoclonal λ-Type IgA Binding to Fibrinogen Caused Lower Functional Plasma Fibrinogen Level and Abnormal Clot Formation. International Journal of Hematology, 112, 96-104. [Google Scholar] [CrossRef] [PubMed]
[8] Zitomersky, N.L., Menno, V. and Trenor, C.C. (2015) Thrombosis and Inflammatory Bowel Disease: A Call for Improved Awareness and Prevention. Inflammatory Bowel Diseases, 17, 458-470. [Google Scholar] [CrossRef] [PubMed]
[9] Mori, T., Murata, M., Wakui, M., Muto, A. and Ikeda, Y. (2010) Acquired Dysfibrinogenemia Following Allogeneic Bone Marrow Transplantation. American Journal of Hematology, 56, 294-295. [Google Scholar] [CrossRef
[10] 孙扬杰, 马林, 方斐, 孙瑞文. 多发性骨髓瘤高纤维蛋白原血症1例报告并文献复习[J]. 基层医学论坛, 2012, 16(11): 1489-1490.
[11] 中国医师协会血液科医师分会, 中华医学会血液学分会, 中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2020年修订) [J]. 中华内科杂志, 2020, 59(5): 341-346.
[12] Chu, T.T., Wang, H., Lv, X., Qi, J.Q., Tang, Y.Q., Fan, Y., et al. (2021) Investigation of Fibrinogen in Early Bleeding of Patients with Newly Diagnosed Acute Promyelocytic Leukemia. Platelets, 32, 677-683. [Google Scholar] [CrossRef] [PubMed]